Role of LOX-1 in Ang II-induced oxidative functional damage in renal tubular epithelial cells

International Journal of Molecular Medicine

Volumn 26, Issue 5, 2010, Pages 679-690

  Xu, Yanfang ^a   Ruan, Shiwei ^a   Xie, Hong ^b   Lin, Jiumao ^a  

^a FUJIAN UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^b FUJIAN MEDICAL UNIVERSITY   (China)

Author keywords

Adhesion molecule; Apoptosis; Oxidized low density lipoprotein receptors; Reactive oxygen species

Indexed keywords

ANGIOTENSIN II; CASPASE 3; CYTOCHROME C; INTERCELLULAR ADHESION MOLECULE 1; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; PROTEIN BCL 2; PROTEIN P22; PROTEIN P47; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 4;

APOPTOSIS; ARTICLE; CELL ADHESION; CELL DAMAGE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME RELEASE; EPITHELIUM CELL; HUMAN; HUMAN CELL; KIDNEY TUBULE EPITHELIUM; MITOCHONDRIAL MEMBRANE POTENTIAL; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

EID: 77957885169     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm_00000514     Document Type: Article

References (36)

1. Zhou MS, Schuman IH, Jaimes EA and Raij L: Renoprotection by statins is linked to a decrease in renal oxidative stress, TGF-beta, and fibronectin with concomitant increase in nitric oxide bioavailability. Am J Physiol Renal Physiol 295: F53-F59, 2008.
2. Kelly KJ, Wu P, Patterson CE, Temm C and Dominguez JH: LOX-1 and inflammation: a new mechanism for renal injury in obesity and diabetes. Am J Physiol Renal Physiol 294: F1136-F1145, 2008.
3. Kim HJ, Moradi H, Yuan J, Norris K and Vaziri ND: Renal mass reduction results in accumulation of lipids and dysregulation of lipid regulatory proteins in the remnant kidney. Am J Physiol Renal Physiol 296: F1297-F1306, 2009.
4. Dominguez JH, Mehta JL, Li D, et al: Anti-LOX-1 therapy in rats with diabetes and dyslipidemia: ablation of renal vascular and epithelial manifestations. Am J Physiol Renal Physiol 294: F110-F119, 2008.
5. Liao TD, Yang XP, Liu YH, et al: Role of inflammation in the development of renal damage and dysfunction in angiotensin II-induced hypertension. Hypertension 52: 256-263, 2008.
6. Chen J, Liu Y, Liu H, Hermonat PL and Mehta JL: Molecular dissection of angiotensin II-activated human LOX-1 promoter. Arterioscler Thromb Vasc Biol 26: 1163-1168, 2006. (Pubitemid 43732128)
7. Li D, Saldeen T, Romeo F and Mehta JL: Oxidized LDL upregulates angiotensin II type 1 receptor expression in cultured human coronary artery endothelial cells: the potential role of transcription factor NF-kappaB. Circulation 102: 1970-1976, 2000.
8. Griendling KK, Minieri CA, Ollerenshaw JD and Alexander RW: Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74: 1141-1148, 1994.
9. Pueyo ME, Gonzalez W, Nicoletti A, Savoie F, Arnal JF and Michel JB: Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-kappaB activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol 20: 645-651, 2000. (Pubitemid 30151676)
10. Hu C, Kang BY, Megyesi J, Kaushal GP, Safirstein RL and Mehta JL: Deletion of LOX-1 attenuates renal injury following angiotensin II infusion. Kidney Int 76: 521-527, 2009.
11. Denizot F and Lang R: Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89: 271-277, 1986.
12. Degterev A, Boyce M and Yuan J: A decade of caspases. Oncogene 22: 8543-8567, 2003.
13. Pagano PJ, Chanock SJ, Siwik DA, Colucci WS and Clark JK: Angiotensin II induces p67phox mRNA expression and NADPH oxidase superoxide generation in rabbit aortic adventitial fibroblasts. Hypertension 32: 331-337, 1998.
14. Ha H and Lee HB: Reactive oxygen species amplify glucose signalling in renal cells cultured under high glucose and in diabetic kidney. Nephrology (Carlton) 10: S7-S10, 2005. (Pubitemid 41743468)
15. Hu C, Dandapat A, Sun L, Khan JA, Liu Y, Hermonat PL and Mehta JL: Regulation of TGFbeta1-mediated collagen formation by LOX-1: studies based on forced overexpression of TGFbeta1 in wild-type and lox-1 knock-out mouse cardiac fibroblasts. J Biol Chem 283: 10226-10231, 2008.
16. Goncalves AR, Fujihara CK, Mattar AL, Malheiros DM, Noronha Ide L, de Nucci G and Zatz R: Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal antiinflammatory. Am J Physiol Renal Physiol 286: F945-F954, 2004.
17. Taniyama Y and Griendling KK: Reactive oxygen species in the vasculature: molecular and cellular mechanisms. Hypertension 42: 1075-1081, 2003.
18. Vaziri ND, Bai Y, Ni Z, Quiroz Y, Pandian R and Rodriguez-Iturbe B: Intra-renal angiotensin II/AT1 receptor, oxidative stress, inflammation, and progressive injury in renal mass reduction. J Pharmacol Exp Ther 323: 85-93, 2007. (Pubitemid 47443257)
19. Ruiz-Ortega M, Lorenzo O, Ruperez M, Konig S, Wittig B and Egido J: Angiotensin II activates nuclear transcription factor kappaB through AT(1) and AT(2) in vascular smooth muscle cells: molecular mechanisms. Circ Res 86: 1266-1272, 2000.
20. Lin CX, Rhaleb NE, Yang XP, Liao TD, D'Ambrosio MA and Carretero OA: Prevention of aortic fibrosis by N-acetyl-serylaspartyl-lysyl-proline in angiotensin II-induced hypertension. Am J Physiol Heart Circ Physiol 295: H1253-H1261, 2008.
21. Cernuda-Morollon E and Ridley AJ: Rho GTPases and leukocyte adhesion receptor expression and function in endothelial cells. Circ Res 98: 757-767, 2006. (Pubitemid 43755259)
22. Cook-Mills JM and Deem TL: Active participation of endothelial cells in inflammation. J Leukoc Biol 77: 487-495, 2005.
23. Li D, Chen H, Romeo F, Sawamura T, Saldeen T and Mehta JL: Statins modulate oxidized low-density lipoprotein-mediated adhesion molecule expression in human coronary artery endothelial cells: role of LOX-1. J Pharmacol Exp Ther 302: 601-605, 2002.
24. Inoue K, Arai Y, Kurihara H, Kita T and Sawamura T: Overexpression of lectin-like oxidized low-density lipoprotein receptor-1 induces intramyocardial vasculopathy in apolipoprotein E-null mice. Circ Res 97: 176-184, 2005. (Pubitemid 41033474)
25. Roebuck KA and Finnegan A: Regulation of intercellular adhesion molecule-1 (CD54) gene expression. J Leukoc Biol 66: 876-888, 1999.
26. Cai H, Griendling KK and Harrison DG: The vascular NAD(P)H oxidases as therapeutic targets in cardiovascular diseases. Trends Pharmacol Sci 24: 471-478, 2003.
27. Ou HC, Lee WJ, Lee IT, Chiu TH, Tsai KL, Lin CY and Sheu WH: Ginkgo biloba extract attenuates oxLDL-induced oxidative functional damages in endothelial cells. J Appl Physiol 106: 1674-1685, 2009.
28. Li D and Mehta JL: Upregulation of endothelial receptor for oxidized LDL (LOX-1) by oxidized LDL and implications in apoptosis of human coronary artery endothelial cells: evidence from use of antisense LOX-1 mRNA and chemical inhibitors. Arterioscler Thromb Vasc Biol 20: 1116-1122, 2000. (Pubitemid 30207591)
29. Chen J, Mehta JL, Haider N, Zhang X, Narula J and Li D: Role of caspases in Ox-LDL-induced apoptotic cascade in human coronary artery endothelial cells. Circ Res 94: 370-376, 2004.
30. Tham DM, Martin-McNulty B, Wang YX, et al: Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs. Physiol Genomics 11: 21-30, 2002.
31. Mehta JL, Hu B, Chen J and Li D: Pioglitazone inhibits LOX-1 expression in human coronary artery endothelial cells by reducing intracellular superoxide radical generation. Arterioscler Thromb Vasc Biol 23: 2203-2208, 2003. (Pubitemid 37532321)
32. Jiang X and Wang X: Cytochrome C-mediated apoptosis. Annu Rev Biochem 73: 87-106, 2004.
33. Yang J, Liu X, Bhalla K, et al: Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132, 1997.
34. Chao J, Li HJ, Yao YY, Shen B, Gao L, Bledsoe G and Chao L: Kinin infusion prevents renal inflammation, apoptosis, and fibrosis via inhibition of oxidative stress and mitogen-activated protein kinase activity. Hypertension 49: 490-497, 2007. (Pubitemid 46263232)
35. Mehta JL, Chen J, Hermonat PL, Romeo F and Novelli G: Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders. Cardiovasc Res 69: 36-45, 2006.
36. Yoshiyama M, Omura T, Takeuchi K, et al: Angiotensin blockade inhibits increased JNKs, AP-1 and NF-kappa B DNA-binding activities in myocardial infarcted rats. J Mol Cell Cardiol 33: 799-810, 2001.